Status:
COMPLETED
Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
This study will evaluate the ability of montelukast to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine and placebo.
Eligibility Criteria
Inclusion
- Patient has a documented history of seasonal allergic rhinitis symptoms that flare up during the study season
- Patient is a nonsmoker and has been a nonsmoker for at least 1 year
- Patient is in good general health
Exclusion
- Patient is hospitalized
- Patient is a woman who is less than 8 weeks postpartum or is breast-feeding
- Patient intends to move or vacation away during the study
- Patient has had any major surgery within 4 weeks of study start
- Patient is a current or past abuser of alcohol or illicit drugs
- Patient has been treated in an emergency room for asthma in the past month
- Patient had an upper respiratory infection with in 3 weeks prior to study start
Key Trial Info
Start Date :
March 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2000
Estimated Enrollment :
1577 Patients enrolled
Trial Details
Trial ID
NCT00979901
Start Date
March 1 2000
End Date
May 1 2000
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.